Sector Focus 

Is patient capital too high-risk?

Is patient capital too high-risk?

Given the slowing global growth outlook, ongoing US and China trade talks and Brexit-related uncertainty, investors are shying away from risk. But despite the fact that investments don’t come much more speculative than venture capital, this anti-risk mood hasn’t translated into a broad-based underperformance in patient capital shares – at least not in the past six months. 

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now